HBK Investments’s Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 CSTA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-107,281
Closed -$34K 686
2022
Q1
$34K Sell
107,281
-6,053
-5% -$2.81K ﹤0.01% 590
2021
Q4
$71K Buy
+113,334
New +$78.9K ﹤0.01% 603

Other funds holding CSTA.WS

HBK Investments's CSTA.WS Position: Q2 2022 in Review

HBK Investments sold out of Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (CSTA.WS) in Q2 2022, closing a stake of 107,281 shares — an estimated $34K sold.

HBK Investments first reported a position in CSTA.WS in Q4 2021 and held it in 2 quarters. The position peaked at $71K in Q4 2021. 52 funds tracked by Wall St. Rank hold CSTA.WS as of Q2 2022.

  • HBK Investments reported no remaining Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
  • HBK Investments sold 107,281 Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q2 2022, an estimated $34K.
  • HBK Investments first reported a position in Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q4 2021 and held it in 2 quarters.
  • HBK Investments's Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $71K in Q4 2021.
  • 52 funds tracked by Wall St. Rank held Constellation Acquisition Corp I Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q2 2022.

Based on HBK Investments's 13F filing for Q2 2022, filed 15 Aug 2022.